Incyte (INCY) Change in Acquisitions & Divestments (2010 - 2026)
Incyte's (INCY) quarterly Change in Acquisitions & Divestments came in at $32.0 million in Q2 2026, down 43.17% YoY from $56.3 million in Q2 2025, and down 54.09% on a QoQ basis from $69.7 million in Q1 2026.
Analysis
Incyte (INCY) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $32.0 million in Q2 2026.
- Quarterly Change in Acquisitions & Divestments fell 43.17% year-over-year to $32.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $284.5 million (up 78.57% YoY) and the FY2025 annual result came in at $284.6 million, changed 0.05% from the prior year.
- Change in Acquisitions & Divestments eased to $32.0 million in Q2 2026, from $69.7 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $125.0 million in Q2 2024 to a low of $258000.0 in Q1 2022.
- A 5-year average of $58.7 million and a median of $56.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 99.27% — and 2023, when it soared 20515.89%.
- Tracing INCY's Change in Acquisitions & Divestments over 5 years: stood at $21.2 million in 2022, then jumped by 285.38% to $81.6 million in 2023, then sank by 97.65% to $1.9 million in 2024, then soared by 3815.82% to $75.0 million in 2025, then tumbled by 57.33% to $32.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $32.0 million (Q2 2026), $69.7 million (Q1 2026), and $75.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.31 Bn | 130.45 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.17 Bn | 77.17 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.25 Bn | 58.07 Bn | 1.37 Bn |
| 4 | Moderna | 58.27 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 40.01 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.26 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.37 Bn | 26.21 Bn | 358.27 Mn |
| 10 | Incyte | 25.53 Bn | 21.00 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.00 Mn |
| Mar 31, 2026 | 69.70 Mn |
| Dec 31, 2025 | 74.99 Mn |
| Sep 30, 2025 | 107.84 Mn |
| Jun 30, 2025 | 56.31 Mn |
| Mar 31, 2025 | 45.49 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 55.61 Mn |
| Jun 30, 2024 | 125.01 Mn |
| Mar 31, 2024 | 102.25 Mn |
| Dec 31, 2023 | 81.56 Mn |
| Sep 30, 2023 | 73.74 Mn |
| Jun 30, 2023 | 97.30 Mn |
| Mar 31, 2023 | 53.19 Mn |
| Dec 31, 2022 | 21.16 Mn |
| Sep 30, 2022 | 14.48 Mn |
| Jun 30, 2022 | 43.25 Mn |
| Mar 31, 2022 | 258,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 124.14 Mn |